Correlation Between Snap and Takeda Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Snap and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Snap and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Snap Inc and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Snap and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Snap with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Snap and Takeda Pharmaceutical.

Diversification Opportunities for Snap and Takeda Pharmaceutical

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Snap and Takeda is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Snap Inc and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Snap is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Snap Inc are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Snap i.e., Snap and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Snap and Takeda Pharmaceutical

Given the investment horizon of 90 days Snap is expected to generate 1.24 times less return on investment than Takeda Pharmaceutical. But when comparing it to its historical volatility, Snap Inc is 1.34 times less risky than Takeda Pharmaceutical. It trades about 0.03 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  2,626  in Takeda Pharmaceutical Co on August 30, 2024 and sell it today you would earn a total of  138.00  from holding Takeda Pharmaceutical Co or generate 5.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy82.22%
ValuesDaily Returns

Snap Inc  vs.  Takeda Pharmaceutical Co

 Performance 
       Timeline  
Snap Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Snap Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively sluggish basic indicators, Snap reported solid returns over the last few months and may actually be approaching a breakup point.
Takeda Pharmaceutical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Takeda Pharmaceutical Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain technical indicators, Takeda Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Snap and Takeda Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Snap and Takeda Pharmaceutical

The main advantage of trading using opposite Snap and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Snap position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.
The idea behind Snap Inc and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data